Bloomberg
Stock Exchange: Top Asia Equities Movers
April 13 -- In today's "Stock Exchange," Bloomberg's Yvonne Man, David Ingles and Rosalind Chin discuss the top three stocks to watch in Asia on "First Up."
Bloomberg
Valeant Scores a Rare Win: Have They Turned a Corner?
July 20 -- Anthony Scilipoti, Veritas Investment Research president and chief executive officer, reacts to the decision by a panel of FDA experts who voted unanimously that Valeant's plaque psoriasis drug, brodalumab, deserved approval....
Bloomberg
The Top Three Stocks to Watch in Asia Today
Feb. 25 -- In today's "Stock Exchange," Bloomberg's Juliette Saly, Rosalind Chin and Yvonne Man discuss the top three stocks to watch in Asia on "First Up."
Bloomberg
Stock Exchange: Top Asia Equities Movers
Feb. 24 -- In today's "Stock Exchange," Bloomberg's Yvonne Man, Juliette Saly and Shery Ahn discuss the top three stocks to watch in Asia on "First Up."
Bloomberg
Sanofi CFO: Offering New Treatments for Diabetes
Feb.08 -- Jerome Contamine, chief financial officer at Sanofi, discusses Donald Trump's comments on drug pricing, their new diabetes drug and M&A in the industry. He speaks exclusively to Bloomberg's Matt Miller and Guy Johnson on...
Bloomberg
Roche CEO: Bullish About U.S. Pharmaceutical Market
Feb.01 -- Severin Schwan, chief executive officer at Roche, discusses President Trumps meeting with pharmaceutical executives, doing business in the U.S. and how Donald Trump's immigration order could impact his business. He speaks to...
Bloomberg
Pfizer en un dilema por el negocio de salud del consumidor
Mar.23-- Ed Hammond de Bloomberg habla del intento de Pfizer Inc. por vender su negocio de salud del consumidor. Conversa con Lisa Abramowicz en "Bloomberg Markets".
Press Association
Shadow Health Secretary on Labour's NHS plans
Shadow Secretary of State for Health and Social Care Jon Ashworth talks about Labour's plans for the NHS outside Kent and Canterbury hospital in Canterbury, and his belief that the Conservatives are planning to allow greater American...
Bloomberg
FTC to Give Big Tech’s Smaller Deals New Antitrust Scrutiny
Feb.12 -- Avery Gardiner, senior fellow at Center for Democracy and Technology, and Adam Haller, partner at Bain & Company, discuss the U.S. Federal Trade Commission’s decision to probe hundreds of startup acquisitions by the largest...
Bloomberg
Trump Says U.S. Is Moving Aggressively to Develop a Coronavirus Vaccine
Mar.03 -- President Trump says the administration is working with pharmaceutical companies to develop a coronavirus vaccine.
Bloomberg
Novartis CEO: Hopeful to Accelerate Growth in Second Half
Jan.26 -- Vas Narasimhan, chief executive officer at Novartis AG, discusses his outlook for the second half of the year, the vaccine rollout and the long-term impact of Covid-19. He speaks on “Bloomberg Markets: European Open.”
Bloomberg
China Has Huge Capacity to Produce Vaccines: RAND's Bouey
Jan.06 -- Jennifer Bouey, senior policy researcher and Tang Chair in China policies studies at think tank RAND Corporation, discusses the Asian nation's handling of the coronavirus pandemic, the rollout of vaccinations, and the...
Bloomberg
Fauci Says Getting Covid Vaccine So Fast Is 'Unprecedented'
Dec.22 -- Dr. Anthony Fauci, the U.S. government’s top infectious-disease doctor, talks about the new Moderna Covid-19 vaccine. “What we’re seeing now is the culmination of years of research,” Fauci said.
Bloomberg
Mumbai’s Municipal Commissioner on Fight Against Covid
May.19 -- Iqbal Singh Chahal, Mumbai's Municipal Commissioner, discusses how the city is dealing with the second wave of the Covid-19 pandemic. Mumbai has reported 2,784 deaths since the second wave began on March 1, around a fourth of...
Bloomberg
FDA Clears Moderna, J&J Boosters and Backs Vaccine Mixing
The U.S. Food and Drug Administration said Moderna Inc. vaccine recipients 65 and over can receive a third shot, and Johnson & Johnson recipients 18 and older are eligible for a booster shot at least two months after receiving their...
Bloomberg
Bristol Myers Plans to Launch Nine New Drugs, CEO Says
Bristol Myers Squibb Chairman and CEO Dr. Giovanni Caforio expects the company's new drugs to generate $10 billion to $13 billion in sales by 2025 and adds that the drugmaker is also looking at small and mid-size bolt-on deals to add to...
Bloomberg
Strong Dollar Does Have Drag on Earnings, CEO Says
Vasant Narasimhan, Novartis CEO, talks about the latest earnings report, the potential sale of its Sandoz generic-drug business, and how it's trying to take more market share in the US. He speaks to Bloomberg's Taylor Riggs.
Bloomberg
J&J Split About 'Unleashing' Consumer Business: CEO
Johnson & Johnson Chairman and CEO Alex Gorsky discusses the decision to split into two publicly traded companies. He speaks with David Westin on "Bloomberg Markets."
Bloomberg
Bayer Exploring Sale of Diabetes Unit for Up to $2.5B
Nov. 24 -- Bayer is exploring the sale of its diabetes device business as the German company focuses on faster-growing medicines. Julie Hyman reports on Street Smart. (Source: Bloomberg)
Bloomberg
Actavis-Allergan: Anatomy of a $66B Deal
Nov. 24 -- Bloomberg's Jeff McCracken examines the inner workings of the $66 billion acquisition of Allergan by Actavis. He speaks on In The Loop.
Bloomberg
Options Update: How to Play Celgene Ahead of Earnings
Sept. 30 -- Recon Capital Partners Strategist Kevin Kelly discusses his options strategy for Celgene with Olivia Sterns on Market Makers. (Source: Bloomberg)
Bloomberg
Siemens Looks to Get Into Shale Gas Boom
Sept. 22 -- Hans Nichols reports on deals between Merck KGaA, Sigma-Aldrich and Siemens, Dresser-Rand Group. He speaks on In The Loop. (Source: Bloomberg)
Bloomberg
Ebola Is Coming and the U.S. Gov't Screwed Up Treatment
Sept. 24 -- ZMapp is a treatment for Ebola that uses human antibodies to create an immunity to the virus. The treatment has been given to some Ebola victims and is credited with saving lives. But there have been no large clinical trials...
Bloomberg
Pfizer Looks Outside U.S. Despite New Tax Rules
Sept. 24 -- Bloomberg's Hans Nichols reports on the U.S. governments attempts to curb corporate tax inversions. He speaks on Bloomberg Televisions On The Move. (Source: Bloomberg)